These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3952014)

  • 1. Successful management of Mycobacterium intracellulare pneumonia in a child.
    Krause PJ; Hight DW; Schwartz AN; Mueller RE; Kleinman LC; Leopold H; Iseman MD
    Pediatr Infect Dis; 1986; 5(2):269-71. PubMed ID: 3952014
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of infections caused by 'atypical' mycobacteria.
    Grange JM
    J Antimicrob Chemother; 1984 Apr; 13(4):308-10. PubMed ID: 6725182
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS.
    Masur H; Tuazon C; Gill V; Grimes G; Baird B; Fauci AS; Lane HC
    J Infect Dis; 1987 Jan; 155(1):127-9. PubMed ID: 3794396
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA; Cheung OT; Sanders DE; Goldstein RS
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental mycobacteria. An increasing problem.
    Griffith DE
    Hosp Pract (Off Ed); 1988 May; 23(5):125-30, 132, 137 passim. PubMed ID: 3131352
    [No Abstract]   [Full Text] [Related]  

  • 6. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
    Casal M; Rodríguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
    J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection.
    Murray MP; Laurenson IF; Hill AT
    Clin Infect Dis; 2008 Jul; 47(2):222-4. PubMed ID: 18532890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The other mycobacteria.
    Davidson PT
    Chest; 1979 Feb; 75(2):110-1. PubMed ID: 421541
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated Mycobacterium chelonei infection: response to sulfonamides.
    Tice AD; Solomon RJ
    Am Rev Respir Dis; 1979 Jul; 120(1):197-201. PubMed ID: 464378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic aspects of the in vitro chemotherapeutic activity of ansamycin (rifabutine) on mycobacterium intracellulare.
    Perumal VK; Gangadharam PR; Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Dec; 132(6):1278-80. PubMed ID: 4073667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of the disease due to mycobacteria other than tubercle bacilli: chemotherapy--with special emphasis on the disease due to M. intracellulare (author's transl)].
    Kita N
    Kekkaku; 1979 Nov; 54(11):543-6. PubMed ID: 522351
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteomyelitis, pericarditis, mediastinitis, and vasculitis due to mycobacterium chelonei.
    Jauregui L; Arbulu A; Wilson F
    Am Rev Respir Dis; 1977 Apr; 115(4):699-703. PubMed ID: 848795
    [No Abstract]   [Full Text] [Related]  

  • 13. THE PATHOGENIC "ATYPICAL" MYCOBACTERIA.
    YOUMANS GP
    Annu Rev Microbiol; 1963; 17():473-94. PubMed ID: 14145309
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycobacterium conceptionense Pneumonitis in Patient with HIV/AIDS
    Michienzi SM; Burgos RM; Novak RM
    Emerg Infect Dis; 2019 Oct; 25(10):1986-1988. PubMed ID: 31538928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course.
    Nei T; Saitoh T; Morimoto K; Watanabe K; Hayashihara K; Azuma A; Kudoh S
    J Infect Chemother; 2007 Oct; 13(5):343-5. PubMed ID: 17982725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs.
    Kuze F; Kurasawa T; Bando K; Lee Y; Maekawa N
    Rev Infect Dis; 1981; 3(5):885-97. PubMed ID: 7339820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
    Ruth MM; van Ingen J
    Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
    [No Abstract]   [Full Text] [Related]  

  • 20. ATYPICAL MYCOBACTERIA IN WESTERN AUSTRALIA.
    CARRUTHERS KJ; EDWARDS FG
    Am Rev Respir Dis; 1965 Jun; 91():887-95. PubMed ID: 14294712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.